Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents
- PMID: 1622113
Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents
Abstract
The effectiveness of various oxygen carrying treatments in sensitizing subpopulations of the FSallC fibrosarcoma to low doses of radiation was assessed, and compared with survivals obtained with the same cells after in vivo irradiation under normally oxygenated or hypoxic conditions. FSallC tumors were treated with 2-10 Gray then the Hoechst 33342 dye diffusion method was used to separate the tumor into bright (enriched in normally oxygenated cells) and dim (enriched in hypoxic cells) subpopulations. There was good agreement between the survival of normally oxygenated cells in culture and bright cells from tumors and between hypoxic cells in culture and dim cells from tumors over a radiation dosage range of 2-5 Gray. At 10 Gray bright cells from tumors were minimally less sensitive to the radiation dose than normally oxygenated cells in vivo. When maximally effective doses of perfluorochemical emulsions (F44E at 4 g PFC/kg or Fluosol-DA at 2.4 g PFC/kg) or a purified bovine hemoglobin solution (PBHS at 1.32 g protein/kg) were administered 1 hr. prior to radiation therapy with carbogen (95% O2, 5% CO2) breathing prior to and during radiation delivery, low single doses of x-ray (2-5 Gray) were measurably more cytotoxic toward both FSallC tumor cell subpopulations. These results indicate that perfluorochemical emulsions or purified bovine hemoglobin preparations along with carbogen breathing may be able to increase tumor radiosensitivity to the relatively low radiation doses per fraction used in the clinic.
Similar articles
-
Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.Int J Radiat Oncol Biol Phys. 1991 Sep;21(4):969-74. doi: 10.1016/0360-3016(91)90737-o. Int J Radiat Oncol Biol Phys. 1991. PMID: 1917627
-
Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.Radiother Oncol. 1990 May;18(1):59-70. doi: 10.1016/0167-8140(90)90023-p. Radiother Oncol. 1990. PMID: 2113698
-
Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.Cancer Res. 1990 Jun 1;50(11):3339-44. Cancer Res. 1990. PMID: 2334928
-
Use of perfluorochemical emulsions in cancer therapy.Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):875-82. doi: 10.3109/10731199209119734. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391527 Review.
-
Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1109-20. doi: 10.3109/10731199409138806. Artif Cells Blood Substit Immobil Biotechnol. 1994. PMID: 7849913 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous